Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001555
Filing Date
2024-02-14
Accepted
2024-02-14 07:26:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 AXSOME THERAPEUTICS, INC. p24-0400sc13ga.htm SC 13G/A 61658
  Complete submission text file 0000902664-24-001555.txt   63329
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Subject) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89198 | Film No.: 24632283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)